Cargando…
Beneficial autoimmunity links primary biliary cholangitis to the avoidance of cholangiocarcinoma
It has been an open conundrum why primary sclerosing cholangitis (PSC) is a major risk factor for developing cholangiocarcinoma (CAA), while primary biliary cholangitis (PBC) is not. In mouse models of PSC and PBC, it turned out that the latter condition, an autoimmune disease affecting the bile duc...
Autores principales: | Pol, Jonathan G., Paillet, Juliette, Plantureux, Céleste, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437477/ https://www.ncbi.nlm.nih.gov/pubmed/34527429 http://dx.doi.org/10.1080/2162402X.2021.1968595 |
Ejemplares similares
-
Beneficial autoimmunity and maladaptive inflammation shape epidemiological links between cancer and immune-inflammatory diseases
por: Pol, Jonathan, et al.
Publicado: (2022) -
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma
por: Paillet, Juliette, et al.
Publicado: (2021) -
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021) -
Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk
por: Nanjundappa, Roopa H., et al.
Publicado: (2023) -
Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions
por: Castedo, Maria, et al.
Publicado: (2018)